2[2]Khuttar RS,Acharya DU,Kinsey C,et al.Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension[J].J Hypertension,1997,15(7):737-743.
3[3]Frankin SS,Lsrson MG,Khan SA,et al.Does the relation of blood pressure to coronary heart disease risk change with aging?The framingham heart study[J].Circulation,2001,103:1245.
4[4]Chobanian AV,Bakris GL,Black FIR,et al.The seventh report of the joint motional committee on prevention,detection,evaluation,and treatment of high blood pressure[J].JAMA,2003,289(19):2560.
5[5]Pitt B.Byington RP,Furberg CD.et al.Effect of amlodipine onthe protression of atherosclerosis and the occurrence of clinical events.prevent investigators[J].Circulation,2000,102:1503.
9[9]Estacio RO,Jeffere BN,Hialt WR,et al.The effect of nisoldipine as compared with enahpric on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension[J].Engl J Med,1998,338:645.
1Otelio SR, Nico W, Gerard CB, et al. Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance[J]. J of Hypertens, 1986,4(Suppl 5) :S293-S296.
2Benetos A, Rudnichi A, Safar M, et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects[J]. Hypertension, 1998,32:560-564.
3Mitchell GF, Moye LA, Braunwald E, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function[J]. Circulation, 1997,96:4254-4260.
4Stanley SF, Shehzad AK, Nathan DW, et al. Is Pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study[J]. Circulation, 1999,100:354-360.
5Verdecchia P, Schillaci G, Borgioni C, et al. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension[J].Hypertension, 1998,32:983-988.
6Khattar RS, Acharya DU, Kinsey C, et al. Longitudinal association of arabulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension[J]. J Hypertens, 1997, 15:737-743.
7Weiss D, Kools JJ, Taylor WR. Angiotensin Ⅱ-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation, 2001, 103: 448-454.
8Li J, Hirose N, Kawamura M, et al. Antiatherogenetic effect of angiotensin converting enzyme inhibitor(benazepril) and angiotensin Ⅱ receptor antagonist(valsartan) in the cholesterol-fed rabbits. Atherosclerosis, 1999, 143: 315-326.
9Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic leision. J Clin Invest, 1996, 97: 1715-1722.
10Baeuerie PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol, 1994, 12: 141-179.
